About the Team
We are LZU-CHINA from Lanzhou University, a multidisciplinary team of students from different
schools, united by curiosity, creativity, and a passion for synthetic biology. From Lanzhou
to Paris, we can’t wait to share our ideas, make new friends, and meet all of you at iGEM
2026!
Project Description
Infectious gastrointestinal diseases remain a major challenge to global health, particularly
among vulnerable populations such as children, older adults, and individuals with impaired
immunity. A wide range of intestinal pathogens, including enteropathogenic Escherichia coli,
Shigella, and Salmonella, can disrupt the balance of the gut ecosystem and cause severe
disease. However, conventional diagnosis often occurs only after noticeable symptoms have
developed, potentially missing the critical window for early intervention.
This year, LZU-CHINA aims to develop a living diagnostic and therapeutic platform based on
the probiotic strain Escherichia coli Nissle 1917 (EcN-1917). Instead of waiting for
intestinal pathogens to cause substantial damage, we want our engineered bacteria to listen
to the molecular conversations occurring among pathogenic bacteria and respond before
infection progresses.
Our design takes advantage of quorum sensing (QS), a communication mechanism through which
bacteria release and detect signaling molecules to coordinate population-level behaviors
such as biofilm formation and virulence. We are developing an integrated sensing system that
enables engineered EcN-1917 to recognize signals associated with both Gram-positive and
Gram-negative intestinal pathogens. By coupling pathogen-associated signal recognition with
downstream genetic circuits, our engineered probiotic is designed to transform otherwise
invisible microbial signals into detectable and actionable outputs.
Once a potential pathogenic population is detected, the system initiates two coordinated
responses. First, a chromogenic reporter module produces a visible signal, providing an
intuitive indication of abnormal pathogenic bacterial activity. In particular, we explore a
β-lactamase-based reporting strategy that can generate a colorimetric output, offering the
possibility of convenient and non-invasive monitoring. Second, a therapeutic module is
designed to express antimicrobial molecules locally, suppressing excessive pathogen
proliferation and helping restore intestinal microbial homeostasis.
Through this “sense–report–intervene” strategy, LZU-CHINA seeks to transform engineered
probiotics from passive therapeutic carriers into autonomous living systems capable of
monitoring and responding to changes in the intestinal environment. By integrating early
detection with timely intervention in a single biological platform, our project explores a
new approach toward more accessible, responsive, and precise management of infectious
gastrointestinal diseases.
Cultural Connection
Listening, Responding, and Restoring Balance: From the Yellow River to the Gut
Ecosystem
LZU-CHINA comes from Lanzhou, a city shaped by the Yellow River and historically connected
with the ancient Silk Road. For centuries, Lanzhou has stood at a crossroads where different
people, cultures, and ideas met, communicated, and influenced one another. This regional
identity inspired us to think about our project not simply as engineering individual
bacteria, but as understanding and participating in a complex network of communication.
Interestingly, the intestinal microbiome is also a world built upon connection and
communication. Thousands of microbial populations coexist in the gut, continuously
exchanging chemical signals and interacting with their surrounding environment. When this
communication remains balanced, a stable microbial ecosystem can be maintained. However,
when pathogenic bacteria proliferate and dominate these interactions, the balance may be
disrupted and disease can emerge.
Our engineered EcN-1917 is therefore designed to listen before it acts. Through
quorum-sensing-associated signals, it detects changes in microbial communication that may
indicate the expansion of pathogenic populations. It then translates these invisible signals
into a visible colorimetric output and, when appropriate, activates an antimicrobial
response. Rather than indiscriminately eliminating microorganisms, our concept emphasizes
sensing the microbial environment, responding to abnormal changes, and ultimately helping
restore ecological balance.
This philosophy resonates with both Lanzhou's regional history and a broader idea deeply
rooted in Chinese culture: harmony does not require uniformity. The Silk Road flourished
because different cultures could meet while retaining their own identities; an intestinal
ecosystem similarly depends on diverse microorganisms coexisting within a dynamic
equilibrium.
From the flowing Yellow River to the microscopic communities within our bodies, balance is
never static—it is continuously negotiated through interaction. Through synthetic biology,
LZU-CHINA hopes to explore how we can listen to these interactions, understand their
signals, and intervene only when the balance begins to break.